Bottom line
Is IVSI a good fund? The bottom line
IVSI is an actively managed international stock ETF from SEI.
Its expense ratio is 0.65% — about $65 a year on every $10,000 invested, cheaper than 74% of international stock funds we track.
With $7.9 million in net assets and 193 holdings, its largest position is ASML Holding NV (6.8%) and the top 10 make up 26.8% of the portfolio.
The closest lower-cost alternative we found is IQLT (0.3%, 56% top-holdings overlap).
What to watch
- Small fund ($7.9 million) — small funds are likelier to close
Updated Nov 19, 2026
What IVSI invests in
The Applied Finance IVS International Large ETF (the Fund) seeks long term capital appreciation.
"Under normal circumstances, the Fund will invest at least 80% of its net assets in equity securities of large-capitalization companies located in developed markets outside of North America, which generally include markets such as Australia, Austria, Belgium, Denmark, Finland, France, Germany, Hong Kong, Ireland, Italy, Japan, Luxembourg, the Netherlands, New Zealand, Norway, Singapore, Spain, Sweden, Switzerland, and the United Kingdom. The Fund defines large cap companies as companies with market capitalizations of $5 billion or more, measured at the time of purchase. In choosing investments, the Adviser typically selects large cap equity securities that it believes offer superior return potential and may consider, among other factors, a companys valuation, projected future earnings, dividends, financing activity, growth potential, recent performance, and business strategy. To select…
From the fund's prospectus (filed Apr 27, 2026).
What IVSI costs
On a $10,000 investment, IVSI's 0.65% expense ratio costs about $65 a year. The prospectus estimates $810 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
IVSI top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | ASML Holding NV ASML | 6.84% |
| 2 | Roche Holding AG ROP | 3.36% |
| 3 | BHP Group Ltd BHP | 2.69% |
| 4 | Novartis AG NOVN | 2.32% |
| 5 | Novo Nordisk A/S NOVOB | 2.16% |
| 6 | Investor AB INVEB | 2.05% |
| 7 | AstraZeneca PLC AZN | 1.93% |
| 8 | British American Tobacco PLC BATS | 1.87% |
| 9 | Deutsche Telekom AG DTE | 1.81% |
| 10 | Allianz SE ALV | 1.78% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 26.8% of the fund. See all top 25 holdings and asset mix →